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Abstract: The mechanism of unidirectional transport of
glutamine from blood to brain in pentobarbital-anesthe-
tized rats was examined using in Situ perfusion. Amino
acid uptake into brain across the blood—brain barrier
(BBB) is classically thought to be via the Na-independent
large neutral (L-system), acidic and basic amino acid
transporters. In the presence of physiological concentra-
tions of amino acids in the perfusate, which should satu-
rate the known amino acid transporters at the BBB, the
cortical transfer constant (I<~)for L-[14C]glutamine was11.6 ± 1.1 ~tl/g/min.The addition of either 10 mM 2-
amino-2-norbornanecarboxylic acid or 10 mM 2-amino-
2-norbornanecarboxylic acid and 5 mM cysteine had no
effect on the cortical K for L-[14C]glutamine, indicating
that glutamine transport under these conditions does not
occur by the L-, A-, or ASC-systems. Decreasing perfu-
sate Na from 140 to 2.4 mM by Tris substitution reduced
the cortical K, for L-[14C]glutamine by 62% (p 0.001).
The Na-dependent uptake has the characteristics of N-
system transport. It was inhibited by L-histidine and L-
glutamine, both N-system substrates, and it was pH sen-
sitive and moderately tolerant of Li substitution for Na.
This putative N-system transporter at the luminal mem-
brane of the BBB plays an important role in mediating
brain glutamine uptake. Key Words: Blood—brain bar-
rier—Transport—Glutamine—N-system—ln situ perfu-
sion.
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Despite the fact that glutamine is the most abundant
amino acid in plasma and CSF and is found at high
concentrations in the brain as a whole, its transport at
the blood—brain and blood—CSF barriers has not been
fully clarified. Studying isolated rat choroid plexus, we
have found that glutamine uptake is mediated by two
systems, the Na-independent L-system amino acid
transporter and a Na-dependent system that also trans-
ports histidine (Keep and Xiang, 1995; Xiang et al.,
1998). The latter resembles the N-system transporter
found in liver (Kilberg et al., 1993) and it has not
previously been described at the blood—brain barrier
(BBB). This system may be of particular importance
in controlling the levels of CSF and brain glutamine
and histidine, as L-system uptake is subject to competi-
tion by many other neutral amino acids (Pardridge,
1986; Smith et al., 1987).
At the cerebral endothelium, the site of the BBB,
much of the initial evidence on mechanisms of amino
acid transport at the luminal membrane came from
the pioneering experiments of Oldendorf and Szabo
(1976), who demonstrated uptake of amino acids into
brain via three systems, the large neutral amino acid
carrier (the leucine-preferring L-system), a basic
amino acid carrier, and an acidic amino acid carrier.
The latter acts as a transporter of glutamate but is of
low capacity. There is clear evidence that the transport
of amino acids at the luminal membrane of the brain
capillary endothelial cell is not through the A- (ala-
nine-preferring; Na-dependent) system (Ennis et al.,
1994; Benrabh and Lefauconnier, 1995). Conflicting
evidence exists for amino acid transport through the
ASC-system (alanine— serine—cysteine preferring; Na-
dependent) at the luminal membrane (Sershen and Laj-
tha, 1979; Wade and Brady, 1981; Tovaret al., 1988).
This study examines whether the N-system is pres-
ent in the luminal membrane of the BBB and character-
izes some of its basic properties, using in situ perfu-
sion. In particular, we examined the following ques-
tions: Is glutamine transport at the BBB Na-dependent;
is it tolerant of Li substitution for Na; is it inhibitable
by histidine; and is it pH sensitive? These are all prop-
erties of the N-system transporter at the rat choroid
plexus (Keep and Xiang, 1995; Xiang et al., 1998)
and liver (Kilberg et al., 1980). In as much as gluta-
mine has significant affinity for the Na-dependent
ASC-system and the N-system, as well as the L-system
Received May 21, 1998; revised manuscript received July 15,
1998; accepted July 15, 1998.
Address correspondence and reprint requests to Dr. S. R. Ennis
at R5605 Kresge I, University of Michigan, Ann Arbor, MI 48 109-
0532, U.S.A.
Abbreviations used: BBB, blood—brain barrier; BCH, 2-amino-
2-norbornanecarboxylic acid; CBF, cerebral blood flow; IMP, iso-
propyliodoamphetamine; pCBF, perfusate cerebral blood flow;
pCPV, perfusate cerebral plasma volume; PS, permeability—surface
area; RBCs, red blood cells.
2565
2566 S. R. ENNIS ET AL.
transporters, we used both 2-amino-2-norbornanecar-
boxylic acid (BCH) and cysteine to probe for transport
of glutamine by the L- and ASC-systems, respectively.
In addition, we examined the pH sensitivity of gluta-
mine uptake at the BBB in vivo, but we did not mea-
sure Na dependence or inhibition by histidine because
of the inability to control these parameters in vivo.
Some of these results were presented in a preliminary
communication (Keep et al., 1997).
MATERIALS AND METHODS
Transport of L-[’4C]glutamine across the BBB was mea-sured by using amodificationof a previously described tech-
nique for in situ perfusion of the rat brain with a perfusate
containing sheep red blood cells (RBCs) (Zlokovié et al.,
1986; Ennis et al., 1994, 1996), but in this instance using
bilateral perfusion. In brief, male Sprague—Dawley rats,
weighing 300—450 g, were anesthetized with pentobarbital
(65 mg/kg i.p.). The right and left common carotid and
pterygopalatine arteries were isolated and ligated. Catheters
of PE-50 tubing, filled with heparinized saline, were placed
in the left femoral artery and in the left and right external
carotid arteries. Rats were heparinized (1.2 U/kg of body
weight) and samples for blood gases obtained from the left
femoral artery. The left andright and common carotid arter-
ies were clamped and a bilateral perfusion initiated through
the external carotid arteries at a rate of 2.5 mi/mm. The
left and right external carotid artery cannulas were used for
retrogradeperfusion of sheep RBCs in saline at atemperature
of 37°C.The chest cavity was opened and the ventricles cut
to prevent recirculation. All of the animals in the present
study had an intact EEG during the time course of a perfu-
sion. A hematocrit of 0.35 wasused for these studies. Supple-
mental pentobarbital (22 mg/kg) was given just before per-
fusion to prevent the animals from awakening during the
perfusion. In addition, pentobarbital at aconcentration of 10
~.tg/mlwas included in the perfusate to maintain anesthesia.
Femoral and carotid blood pressures were recorded continu-
ously throughtransducers connected to the arterial catheters.
Blood pressure and EEG were recorded by using a Biopac
MP100 data-acquisition system. The body temperature was
maintained between 37.5 and 38.5°Cby using arectal therm-
istor connected to atemperature monitor/controller. Animal
use for these studies was approved by the University of
Michigan University Committee on Use andCareof Animals
and meets NIH guidelines.
Measurement of blood-to-brain transport during
in situ perfusion
Blood-to-brain transfer constants (K,) for L-[‘4C I gluta-
mine (0.025 pCi/mI) were determined by using a 5-mm
perfusion. After the perfusion, the brain was removed, the
hemispheres bisected, and dissected into frontal, parietal,
and occipital cortices and diencephalon, cerebellum, and
brainstem. Brain and perfusion fluid samples were dissolved
in methylbenzthonium hydroxide and prepared for liquid
scintillation counting.
Composition of perfusion fluids
Blood was stored at 4°Cuntil the day of use. Whole blood
was centrifuged at 1,660 g for 10 mm at 8°C,and the plasma
and white blood cells were discarded. The lightly packed
RBCs were washed twice by centrifugation in 1.5 volumes
of 0.9% NaC1 and twice by centrifugation in 1.5 volumes
of perfusate saline. After thefinal spin, the RBCs were resus-
pended at a hematocrit of 0.35 in saline. The composition
of the control saline used to make theRB C-containing perfu-
sate was (mM) 117 NaCI, 4 KC1, 1.2 MgSO
4, 1.2 NaH2PO4,
25.1 NaHCO3, 2.5 CaCl2, and 5 glucose. The perfusate also
contains the following 19 amino acids at the average physio-
logical levels (mM) (Jeppsson et al., 1985; Milakofsky et
al., 1985; Smith et al., 1987; Hageman and Eriksson, 1990)
found in plasma: 0.3 alanine, 0.22 arginine, 0.07 asparagine,
0.02 cysteine, 0.06 glutamate, 0.42 glutamine, 0.23 glycine,
0.07 histidine, 0.09 isoleucine, 0.16 leucine, 0.44 lysine, 0.06
methionine, 0.08 phenylalanine, 0.22 serine, 0.1 taurine, 0.37
threonine, 0.07 tryptophan, 0.07 tyrosine, and 0.18 valine.
The perfusate containing radioactive isotopes was gently
bubbled with a mixture of oxygen and carbon dioxide to
maintain the pH in the range 7.35—7.45.
Two different Na replacement experiments were per-
formed. In one set, mixtures of Tris-HC1 and Tris-base and
24 mM Tris-carbonate were used as replacement for NaC1
and NaHCO3 (1 mM Na experiments). In the second set,
Na substitution experiments used LiC1 and Li2CO3 in place
of NaC1 and NaHCO3 (143 mM LiC1 experiments). Na and
K concentrations were confirmed by using a flame photome-
ter (IL 943).
Normocapnic perfusates with either a low or high pH were
created by changing the amount of NaHCO3, along with
appropriate changes in the amount of NaCl included in the
perfusate, to maintain a constant osmolality. The low pH
perfusate contained (in mM) 132 NaC1, 4 KC1, 1.2 MgSO4,
1.2 NaH2PO4, 9.98 NaHCO3, 2.5 CaC12, and 5 glucose, with
apH of 7.05 ±0.03. Thehigh pH perfusate contained(mM)
79 NaC1, 4 KC1, 1.2 MgSO4, 1.2 NaH2PO4, 62.9 NaHCO3,
2.5 CaC12, and 5 glucose, with a pH of 7.75 ±0.01.
Calculation of rate constants for BBB
permeability to glutamine
The K~for movement of soluteacross the BBB was calcu-
lated from the following equation:
K~= A5/(C~x T) (1)
Ab is the amount of solute in the brain per unit mass of tissue
(dpmlg), C~is theperfusate solute concentration (dpmlml),
and T is time. In the present experiments C~is constant.
The K, values measured in this study were <4% of the
rate of measured blood flow. Consequently, K~closely ap-
proximates the permeability—surface area (PS) product as
described by Fenstermacher et al. (1981). The PS for a
substance at the BBB is the product of the permeability (P)
(cm/mm) and the surface area (5) (cm
2/g).
Uptake data w re corr cted for the amount of tracer that
remains within thevascular space of the brain by the follow-
ing equation:
Ab = AT — (pCPV x Ci,) (2)
AT is the amount of solute in the brain per unit mass of
tissue (dpmlg). The pCPV is the perfusate cerebral plasma
volume. The pCPV was determined for each animal from
the amount of [3HI inulin (2-mm circulation) in the brain
samples (assuming no tissue uptake).
The time of isotope perfusion was 5 mm. The transfer
constant for glutamine was measured with in situ perfusion
of sheep RBCs in the following four groups of rats: group
1, animals perfused with a saline containing either 15 mM
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mannitol (n = 6), or 5 mM mannitol and 10 mM BCH, a
model amino acid substrate for the L-system transporter (n
= 5), or 5 mM cysteine, a substrate for the A-, ASC-, and
L-system transporters, and 10 mM BCH (n = 6); group 2,
animals perfused with a saline containing either 142 mM
Na (n = 9), or 1 mM Na (n = 9), or 143 mM LiC1 (n
= 6); group 3, animals perfused with a saline containing
2.5 mMhistidine with either 142 mM Na (n = 4), or 1 mM
Na (n = 4), and 10 mM glutamine with either 142 mM Na
(n = 6), or 1 mM Na (n = 6); group 4, animals perfused
with saline with a pH of 7.4, containing 25.1 mM NaHCO3
(n = 9), or saline with a pH of 7.0 containing 10 mM
NaHCO3 (n = 5), or saline with a pH of 7.8 containing 63
mM NaHCO3 (n = 5).
The transfer constant for giutamine was also determined
from amultiple time/graphical analysis. Thefollowing equa-
tion describes the relationship between the amount of tracer
in the brain (A5) and its concentration in plasma:
Ab=~XfCPdt+VhXCP(T)
Vb is the sum of the plasma and rapidly filling spaces (Vb
= pCPV + Vr). Vr is termed therapidly filling spacebecause
it rapidly and reversibly exchanges with plasma (Patlak et
al., 1983). Under initial velocity conditions, a plot of A5/
C~(T)versus perfusion time is a straight line with the slope
= K, andthey intercept = Vb. The time of isotope circulation
ranged between 0.5 and 10 mm.
The uptake of glutammne by the sheep RBCs was also
measured in each experiment. During the time course of the
experiments shown in Fig. 1, there was no significant uptake
of glutamine by sheep RBCs. The glutamine space in the
RBC, relative to the plasma, averaged —0.04 ± 0.044
~il/j.tg (n = 6) at 5 mm of circulation.
In addition, the transfer constant for L- [
4C I glutammne
was measured in vivo, using Eq . I and 2 as described pre-
viously (Betz et al., 1989). The effect of changing plasma
pH was measured in the following four groups of animals
(each n = 5) 1 h after an intraperitoneal injection, at a dose
of 20 ml/kg, of: 235 mM NaC1, 235 mM HCI, 235 mM
NaHCO
5, or 235 mM NH4CI.
Perfusate cerebral blood flow (pCBF)
The pCBF was calculated by using [
14C]isopropyliodo-
amp tamine ([‘4C I IMP) as the blood flow indicator. IMP
has a high effective partition coefficient between brain and
blood that approaches 25:1 (Lear et al., 1982). Other investi-
gators have found that IMP uptake in brain represents cere-
bral blood flow (CBF) for at least the first 15 mm after tracer
administration (Rapin et al., 1984). Under these conditions,
the pCBF was calculated as follows:
pCBF = Ah/(C~X T)
Animals (n = 4) were preperfused for 2.5 mm with the
appropriate solution before determining the pCBF. Radiola-
beled IMP was perfused into the external carotid arteries for
30 s in order to measurepCBF. The CBF was also measured
in viva by using Eq. 4 and [14ClIMP with a 30-s circulation
time. The in viva CBF was measured in a group of four
animals. In addition to the cortical samples, basal ganglia,
and brainstem, the choroid plexuses from the lateral and the
fourth ventricle were sampled.
Statistical analysis
Data from single time point experiments (Eq. 1) were
analyzed using a model I ANOVA with either an unpaired
two-tailed t test, or with a two-tailed Bonferroni post hoc
test for multiple comparisons. The data for the effect of pH
on the in viva or in situ uptake of glutamine into the cortex
were analyzed by least-squares linear regression. The results
were subjected to an analysis of covariance with a two-
tailed t test. The Systat statistical software was used for these
comparisons. Ap value of <0.05 was consideredsignificant.
All data aremean ±SD values, except where noted as SEM.
Chemicals and radiotracers
[3H]Inulin, L-[’4C]glutamine, and [‘4C]IMP were pur-
chased from DuPont—NEN (Boston, MA, U.S.A.). All other
chemicals were obtained from Sigma Chemical (St. Louis,
MO, U.S.A.).
RESULTS
Table 1 presents the average perfusate values for
blood gases, physiological parameters, osmolality, and
Na, K, and glucose concentrations. These data were
measured just before the beginning of a perfusion. The
data are presented in groups that correspond to the
major change made in the perfusate. For example, the
Na concentration for the 1 mM Na group was 2.2 ±0.9
mM in comparison with the control value of 137 ±5
mM (p ~ 0.001). The only unanticipated differences
were in the pH and Pco
2 between the control and the
1 mM Na groups and the Pco2 between control and
the pH 7.0 groups. These were small changes that
would not affect glutamine transport.
Table 2 presents a comparison of cerebral plasma
volume, measured as the inulin space, and blood flow
measured both in viva and in situ (with control perfu-
sate). Plasma volume in the cortex during bilateral in
situ perfusion at a rate of 2.5 ml/min with washed
sheep RBCs was reduced 17% (p ~ 0.01) compared
with in vivo values. In a similar manner, CBF in the
cortex was reduced 18% (p 0.01) compared with
in vivo values. These small differences in perfusion
during in situ perfusion should not adversely effect
determination of the mechanism of transport (see be-
low for a comparison of effect of pH on glutamine
transport). The inulin space and blood flow were also
measured in the lateral and fourth ventricle choroid
plexuses. The inulin space for the choroid plexus actu-
ally represents a combination of the residual vascular
volume and the extracellular space of this tissue. Table
3 presents the combined value for these tissues. The
in vivo and in situ values for the choroid plexuses are
(4) very similar to published values (Deane and Segal,
1985; Szmydynger-Chodobska et a!., 1994).
The plasma volume (Table 3) during in situ perfu-
sion was measured in groups that correspond to the
major change made in the perfusate, simultaneously
with glutamine K,. The animals in which the plasma
bicarbonate level was reduced to 10 mM showed a
statistically significant increase in plasma volume
when compared with control animals (p 0.001).
Graphical analysis of glutamine transport
Graphical analysis of multiple time data was used
to confirm that glutamine transport in the presence of
(3)
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TABLE 1. Physiological parameters
Control 1 mM Na LiC1 pH 7.0 pH 7.8
(n = 45) (n = 19) (n = 6) (n = 5) (n = 5)
Weight (g) 304 ±23 287 ±27 287 ±27 300 ±34 282 ±20
Perfusion pressure (mm Hg) 108 ±29 122 ±25 93 ±25 110 ±18 126 ±22
Perfusate pH 7.38 ±0.04 7.48 ±0.03” 7.37 ±0.04 7.05 ±0.03” 7.74 ±0.01”
Perfusate Pco2 (mm Hg) 37 ±4 51 ±5” 38 ±4 48 ±9” 37 ±2
Perfusate P02 (mm Hg) 215 ±37 189 ±55 241 ±13 232 ±16 206 ±10
Perfusate hematocrit (%) 34 ± 1 32 ±1 35 ±1 34 ±0.5 33 ±2
Perfusate glucose (mg/dl) 89 ±13 87 ±8 80 ±5 81 ±9 89 ±4
Perfusate Na (mEqfL) 137 ±5 2.2 ±0.9” 1 ±0.5” 133 ± 1 137 ±3
Perfusate K (mEqfL) 4.1 ±0.6 4.1 ±0.1 4.1 ±0.1 3.7 ±0.1 3.8 ±0.1
Perfusate osmolality (mOsmIL) 286 ±14 287 ±13 274 ±9 286 ±6 281 ±II
Data are mean ±SD values. Perfusion pressure is the carotid pressure minus the pressure due to the carotid cannula. n = number of animals.
“p ~ 0.001.
physiological concentrations of 19 of the most com-
mon amino acids (including 0.42 mM glutamine) re-
mained unidirectional during the typical uptake experi-
ment. Figure 1 presents a graphical analysis for gluta-
mine uptake in the frontal cortex during in situ
perfusion, using time points of 0.5, 2.0, 5, and 10 mm
of circulation time. Inspection of the regression line
for linearity indicates that during the 10 mm of the
perfusion, glutamine transport remained unidirectional.
The transfer constant for glutamine during perfusion
with a perfusate containing physiological concentra-
tions of amino acids was 10.4 ±0.4 jil/g/min with a
rapidly filling space of 13.1 ±2.3 ~.tl/g. Data are mean
±SEM values. The K, during in situ perfusion, using
a single time point analysis, with a 5-mm time point,
was 10.8 ±0.6 ~tl/g/min. The results validate the use
of 5-mm, single time point studies for the remainder
of this study.
Glutamine transport at the luminal membrane of
the BBB
Glutamine uptake was measured in the presence of
either 15 mM mannitol (control), 10 mM BCH with
5 mM mannitol, or 10 mM BCH and 5 mM cysteine
(Fig. 2). The K, of L- [‘
4C]glutamine uptake into the
cortex was 11.6 ±1.04 ml/g/min (mean ±SD). To
determine if this rather large influxwas due to transport
by the L-system transporter, an excess (10 mM) of
BCH, the model amino acid for system-L, was added
to the perfusate. BCH failed to significantly reduce the
K, of L- [14C I glutamine transport into the cortex, basal
ganglia, cerebellum, or brainstem. In a similar manner,
10 mM BCH and 5 mM cysteine, a substrate for the
ASC- and A-system transporters, did not inhibit trans-
port L- [‘4CI g!utamine into the cortex or basal ganglia.
However, the combination of BCH and cysteine did
slightly reduce uptake of L-[14C I glutamine into the
cerebellum and brainstem. These results indicate that
glutamine transport, in the presence of this comple-
ment of amino acids, does not enter the brain through
either the L- or the ASC-system at the luminal mem-
brane of the BBB.
Effect of Na and Li concentration on glutamine
transport
None of the known L-amino acid transport systems
at the luminal membrane of the BBB show Na-depen-
dent transport. Of the described carrier-mediated sys-
tems at the luminal membrane of the BBB, only ~3-
~taurine transport is Na-dependent (Benrabh et a!.,
1995). Na-dependent glutamine transport was tested
by substituting Tris-HC1 for NaC1 and Tris-carbonate
TABLE 2. Comparison of inulin space and CBF
Region
Inulin space (jug) CBF (mug/mm)
viva situIn In In vivo In situ
Cortex 5.9 ±0.5” 4.8 ±0.4k 0.56 ±0.06 0.46 ±0.02”
Basal ganglia 7.0 ±0.7 5.8 ±0.6” 0.73 ±0.11 0.48 ±0.02k
Cerebellum 8.2 ±0.9 6.7 ±0.4” 0.73 ±0.13 0.51 ±0.03”
Brainstem 9.1 ±3.3 6.3 ±0.7 0.81 ±0.11 0.50 ±0.02k
Choroid plexus 217 ±27 309 ±45” 4.8 ±1.1 6.8 ±1.3”
The inulin space for the choroid plexus is a combination of residual vascular volume and extracellular
space of the tissue, whereas for the other tissues it just represents the vascular volume. Data are mean
±SD values, n = 4, for both in vivo and in situ.
In vivo vs. in situ: “p 0.05; “p ~ 0.01.
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Control 6.1 ±1.2 36
lmMNa 5.0±0.5 10
LiCI 5.3 ±0.4 6
10 mill NaHCO
3 (pH 7.0) 8.2 ±0.8” 5
63 mM NaHCO3 (pH 7.8) 5.1 ±0.7 5
Data are mean ±SD values.
“p 0.01 vs. control.
for NaHCO3 (Ennis eta!., 1996). The final Na concen-
tration in these experiments was 2.4 ±1.0 mM (n
= 9). Na replacement reduced glutamine transport by
62, 58, 58, and 54% (allp 0.001) in the cortex (Fig.
3), basal ganglia, cerebellum, and brainstem, respec-
tively.
The Na-dependent glutamine transporter (system-
N) shows varying tolerance for Li substitution for Na,
depending on the tissue studied. Using in situ perfu-
sion, we found that Li substitution resulted in a 44%
decrease (p 0.001) in the Na-dependent portion of
glutamine uptake into the cortex (Fig. 3). In a similar
manner, Li substitution reduced glutamine transport by
44, 48, and 53% in the basal ganglia, cerebellum, and
brainstem, respectively.
Na-dependent L- [‘
4C] glutamine transport: effect
of histidine and glutamine
N-system transport in other tissues has a restricted
range of substrates that includes glutammne, histidine,
and asparagine. Of these three, histidine and glutamine
are the most effectively transported by the N-system
(Kilberg et al., 1993). The effect of adding either 2.5
mM histidine or 10 mM glutamine to the perfusate on
the total and Na-independent uptake of L- 14C] gluta-
mine is presented in Fig. 4. The Na-dependent uptake
was calculated by subtracting the totaland Na-indepe~n-
dent values. Both histidine and glutamine significantly
reduced the total uptake by 50 and 64%, respectively
(both p 0.001). The Na-independent transport of L-
[14CI glutammne in the presence of histidine was sig-
nificantly less (p 0.001) than the total (in the pres-
ence of histidine). This was most likely because an
FIG. 1. Graphical analysis of in
situ uptake of L-[14C]glutamine
into the cortex in the presence of
physiological concentrations of
amino acids. Data were best fit by
linear-regression analysis to Eq.
3. The slope of the line is the
transfer constant (K,) and the in-
tercept is Vr, !<i = 10.4 ± 0.4
jsl/g/min, and V, = 13.1 ±2.3
jil/g, r = 0.992. Data are mean
±SEM values.
FIG. 2. Effect of substrates of the L- (BCH) or A- and ASC-
(cysteine) transport systems on the K, for L-[14C]glutamine at
the BBB. In the presence of physiological concentrations of
amino acids (including 0.42 mM glutamine) in the pertusate, the
K, for L-[”C]glutamine uptake into the brain was 11.6 ±1.1
jsl/g/min. Neither BCH, the model substrate for the L-system
transporter, nor a combination of BCH and cysteine substantially
reduced the glutamine K,. Data are mean ±SD values, n = 6
for 15 mM mannitol, n = 5 for 10 mMBCH and 5 mMmannitol,
and n = 6 for 10 mM BCH and 5 mM cysteine. p values are
shown for comparison with the mannitol control group. *p
0.05; °°p 0.01.
additional 2.5 mM histidine did not completely inhibit
Na-dependent glutamine transport. Na-dependent glu-
tamine transport was statistically higher in the presence
of 2.5 mM histidine than in the presence of 10 mM
g!utamine (p ~ 0.01). As reported above, Na replace-
ment reduced L- [ 4C I glutamine uptake by 62% into
the cortex. Neither histidine nor glutammne had any
further statistically significant effect on Na-indepen-
dent transport of L- [‘4C I glutamine, indicating that its
transport in the present experiments is through the Na-
dependent pathway. The Na-dependent portion of glu-
tamine transport was reduced 63% by 2.5 mMhistidine
and 90% by 10 mM glutamine (both p 0.001, corn-
FIG. 3. Effect of either reducing perfusate Na from an average
of 138 ±2 to 2.4 ±1 mEq/L or replacing perfusate Na(0.7 ±0.6
mEq/L) with LiCI. Physiological concentrations of amino acids
(including 0.42 mM glutamine) were included in the perfusate.
Decreasing perfusate Na from 140 to 2.4 mM reduced the corti-
cal K~for L-[14C]glutamine by 62% (p < 0.001). In contrast,
replacing Na with Li resulted in a 27% decrease in the cortical
I<~for L-[14C]glutamine. Data are mean ±SD values, n = 9 for
NaCI, n = 6 for LiCI, and n = 9 for low Na. p values are shown
for between pairs (inserts) or for the comparison of low Na to
NaCI (brackets). °p 0.05; ~ ~ 0.001.
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0.001). We believe that this difference is due to the
longer exposure time to an altered blood pH in vivo
and a larger pH gradient between blood and the endo-
thelial cells of the BBB and to small changes in plasma
g!utamine concentration (not measured) during manip-
ulation of blood pH (We!bourne, 1987).
DISCUSSION
FIG. 4. Effect of adding 2.5 mM histidine or 10 mM glutamine
on the total, Na-independent or the Na-dependent transport of
L-[14C]glutamine into the cortex. The Na-dependent transportwas calculated by subtraction of the total and Na-independent
transport. These experiments were all performed in the presence
of physiological concentrations of amino acid, including 0.42
mM glutamine and 0.07 mM histidine. Data are mean ±SD
values, n = 9 for experiments with normal amino acid composi-
tion, n = 4 for 2.57 mM histidine experiments, and n = 6 for 10
mMglutamine experiments. p values are shown for comparison
of Total to the indicated group (***p 0.001), or histidine with
and without Na (~~p~ 0.001), or Total Na-dependent gluta-
mine transport with either histidine or glutamine (~j~(p 0.001),
or Na-dependent glutamine transport with histidine compared
with Na-dependent glutamine transport with glutamine (~j~p
0.01).
pared with control). These results indicate that in the
presence of physiological concentrations of the amino
acid glutammne, the transport at the luminal membrane
of the BBB is through a Na-dependent carrier that is
probably the N-system transporter.
Effect of pH on L- [‘4C]glutamine uptake:
comparison of in vivo and in situ transport
Glutamine transport through the hepatic N-system
shows a marked sensitivity to extracellular pH, with a
60% reduction in transport at pH 7.0 and a 60% in-
crease in transport at pH 8.0, both compared with the
rate at pH 7.5 (Kilberg eta!., 1980). Figure 5 presents
the regression lines describing the relationship between
extracellular pH and glutammne transport into the cere-
bral cortex both in situ (A) and in viva (B). During
in situ perfusion, we varied the perfusate pH by chang-
ing the perfu sate content of NaHCO
3, while holding
the CO2 approximately constant. The BBB was ex-
posed to a changed pH for only 6 mm. At a pH of
—~7.0(pH = 7.05 ±0.03, mean ±SD; n = 5), the
glutamine K, was reduced to 43% of the value at pH
7.4 (pH = 7.39 ±0.03, n = 9), while a pH of 7.8
(pH = 7.75 ±0.01, n = 5) increased the glutamine
pH to 139% of the value at pH 7.4. To verify that
uptake of glutamine at the BBB is pH dependent we
also measured glutammne uptake in viva by imposing
a metabolic acidosis or alkalosis 1 h before isotope
injection. Over the narrower pH range that these ma-
nipulations produced, glutamine K, again varied as a
function of pH, but the slope of the line describing
this relationship was larger in vivo than in situ (p
Comparison of in vivo and in situ plasma volume
and CBF
In situ perfusion has proven valuable in clarifying
mechanisms of transport at the luminal membrane of
the BBB. It allows for precise control of the composi-
tion of the perfusate, avoids recirculation of radioactive
metabolites from the systemic circulation, and allows
for constant plasma levels of radioactive tracers to be
delivered to the brain. Mechanisms for amino acid
(Smith, 1991), sodium (Ennis et al., 1996), and pep-
tide transport (Zlokovié et a!., 1989; Zlokovi~,1995),
have been successfully determined using this method.
However, in situ perfusion relieson artificialperfusates
and sets CBF and perfusion pressure with an external
pump. Consequently, it is necessary to validate the
parameters for perfusion by using in vivo methods.
Table 2 presents a comparison of cerebral plasma vol-
ume and CBF measured both in vivo and in situ. Both
the plasma volume and the CBF showed minimal
(<20%) reductions compared with in viva values.
Theseresults validate the flow rate and the use of sheep
RBCs during in situ perfusion in order to approximate
in viva cerebral perfusion. The use of a bilateral perfu-
sion also allowed us to measure the plasma volume/
extracellular space and blood flow in the lateral and
fourth ventricle choroid p!exuses. The in vivo and in
FIG. 5. Comparison of the effect of pertusate pH on the cortical
K~L-I
14 lglutamine measured either in situ (A) r in viv (B).
During in situ perfusion physiological concentrations of amino
acids were included in the pertusate. The in situ glutamine K, for
the cortex was measured after changing the perfusate pH
through manipulation of the NaHCO
3 concentration. The time of
exposure to the pertusate in situ was 6 mm. The in viva glutamine
K, for the cortex was measured 1 h after intraperitoneal injections
(20 mI/kg) of 235 mM NaCI, NaHCO3, HCI, or NH4CI. The line
describing K1 as a function of pH in situ is: K~= 14.8 x pH — 96.9,
r
2 = 0.95, and in vivo K, varies as a function of pH: K~= 25.7
x pH — 175.5, r2 = 0.84. The difference in the slope of these
two lines (p 0.001) probably reflects the different times of
exposure of the BBB to an altered pH.
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situ values are very similar to published values (Deane
and Sega!, 1985; Szmydynger-Chodobska et a!., 1994)
and indicate that this vitalportion of the barrier system
of the brain is functioning during the present experi-
ments.
Glutamine transport at the luminal membrane of
the BBB
This study introduces evidence that a transporter for
glutamine is present at the luminal membrane of the
rat BBB. We have tentatively identified this transporter
as the N-system based on the following evidence: (1)
Glutamine transport is Na-dependent and shows mod-
erate Li tolerance; (2) glutamine transport at the BBB
shows marked pH sensitivity both in vivo and in situ;
(3) Na-dependent glutamine uptake shows self-inhibi-
tion; (4) BCH, a model substrate for the L-system,
and cysteine, a substrate for A- and ASC-systems (both
Na-dependent), does not inhibit glutamine transport;
and (5) Na-dependent glutammne transport is inhibited
significantly by histidine.
The known Na-independent amino acid carriers at
the luminal membrane include the L-system for phe-
nylalanine, tryptophan, and leucine (Smith et a!.,
1987), the basic (cationic or y~)for lysine and argi-
nine (Stall et a!., 1993), and the acidic (x) amino
acid transporter for glutamine and aspartate (Davson
eta!., 1990; Al-Sarrafet al., 1995). There is evidence
that transport of amino acids at the luminal membrane
of the brain capillary endothelial cell is not through
either the A- (alanine-preferring; Na-dependent) or
ASC- (alanine-serine-cysteine preferring; Na-depen-
dent) systems (Ennis et a!., 1994; Benrabh and Lefau-
connier, 1995). The Na dependence of glutamine
transport, combined with the observation that excess
(10 mM) BCH did not further reduce the glutammne
K,, indicates that glutamine transport into the brain is
most probably through a novel transporter. Adding 10
mM glutamine to the perfusate inhibited Na-dependent
glutamine transport into the cortex by ‘-“90%. Gluta-
mine uptake at the lumina! membrane of the BBB was
measured in the presence of physiological concentra-
tions of 19 of the most common amino acids (including
0.42 mM glutamine). Smith et al. (1987) calculated
that a amino acid composition similar to the one we
used would saturate the L-system transporter at the
BBB. The absence of any major inhibition of glutamine
uptake by BCH does not imply that glutamine cannot
be transported by the L-system transporter in the ab-
sence of competing amino acids. It does indicate that
under physiological conditions, !uminal L-system
transport is not a major contributor to brain glutamine
uptake.
Glutamine transport at the luminal membrane of the
BBB showed moderate Li tolerance and marked sensi-
tivity to intravascular pH, and inhibition by histidine,
all characteristics of N-system transport in liver (Kil-
berg et a!., 1980), astrocytes (Nagaraja and Brookes,
1996), and choroid plexus (Keep and Xiang, 1995;
Xiang et a!., 1998). The Na-dependent glutamine
transporter (system-N) shows varying tolerance for Li
substitution of Na, depending on the tissue studied
(Kilberg et al., 1980; Hundal et a!., 1987; Nagaraja
and Brookes, 1996; Tamarappoo et a!., 1997). The
system-N transporter in rat brain neurons and perfused
rat hindlimb have been described as only weakly toler-
ant of Li substitution whereas those in rat liver hepato-
cytes, rat sarcolemmal vesicles from skeletal muscle,
and mouse astrocytes are characterized as strongly Li
tolerant. In the choroid plexus, the system-N-like gluta-
mine transport was also tolerant of Li but showed a
33% decrease in Na-dependent transport that was not
statistically significant (Keep and Xiang, 1995). Of
the known Na-dependent transporters only the A-sys-
tem also shows a marked pH sensitivity (Kilberg et
a!., 1980), and this is not present at the luminal mem-
brane of the BBB (Ennis et a!., 1994; Benrabh and
Lefauconnier, 1995).
Smith et al. (1987) have also used in situ brain
perfusion to measure BBB g!utamine transport. Their
influx in the presence of normal concentrations of
plasma amino acids (4.1 nmo!/g/min) is very similar
to that found in this study (4.9 nmo!/g/min). These
authors also determined kinetic constants for glutamine
transport (Vmax of 43.2 nmol/g/min, a Km of 0.88 mM,
and a K0 of 2.4 ,ul/g/min) (Smith et al., 1987). In
analyzing the effect of competition of other neutral
amino acids on glutamine uptake, these investigators
assumed that glutamine transport was only through the
L-system amino acid carrier. However, the results of
the present study indicate that a second carrier (N-
system) also transports glutamine at the lumina! mem-
brane of the BBB. Consequently, the Vmax and Km for
glutamine transport calculated by Smith et al. (1987)
should represent some combination of the maximum
velocity and the affinity of glutamine for the L- and
N-system amino acid transporters at the BBB. The K0
calculated by Smith et a!. (1987) should represent an
accurate value for glutamine diffusion at the BBB.
Only two other groups have investigated glutamine
transport at the luminal membrane of the BBB (Olden-
dorf, 1971; Pardridge and Mietus, 1982). Pardridge
and Mietus (1982) found a faster rate of glutamine
transport in newborn rabbit brain compared with adult
rat (Oldendorf, 1971). In contrast to the present report,
they found that glutamine transport was Na-indepen-
dent using the carotid injection technique and a Na
concentration of 50 mM (Pardridge and Mietus,
1982). In addition to the different species used, another
possible reason for the different results may be that
we used a Na concentration of 1 mM to test the Na
dependence of glutamine transport. Alternatively, the
results of Pardridge and Mietus (1982) raise the inter-
esting possibility that Na-dependent glutamine trans-
port by the N-system at the BBB may not develop
until later in neonatal life.
A very recent report has provided evidence, using
fractionated vesicles from bovine brain endothelial
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cells, that the N-system transporter is probably present
on the ablumina! as well as the luminal membrane
(Lee et al., 1998). The role an abluminal transporter
plays in the overall nitrogen balance of the brain re-
mains to be clarified.
Role of N-system transport at the BBB
The combined unidirectional flux of L-aminO acids
into the brain has been calculated as =“53 nmo!/g/
mm (Smith et a!., 1987). Our calculated unidirectional
glutamine flux out of an artificial plasma of 4.9 nmol/
g/min is ~—~10%of this total L-amino acid flux and
highlights the potential importance of glutamine trans-
port into the brain for its overall nitrogen balance.
Much of the interest in glutamine in the brain centers
on hepatic encephalopathy where detoxification of am-
monia in the brain results in a buildup of glutamine
(Cooper and Plum, 1987). This accumulation of gluta-
mine appears to be involved in the pathophysiology of
this condition as methionine sulfoximine, an inhibitor
of glutamine synthetase can prevent the metabolic
symptoms, brain edema (Hawkins and Jessy, 1991;
Hawkins et al., 1992), and brain amino acid changes
associated with hyperammonemia (Rigotti et a!.,
1985).
The rate of glutamine synthesis in the brain of nor-
mal, pentobarbital-anesthetized rats is markedly higher
(40 nmol/g/min; Sibson et a!., 1998) than the unidi-
rectional influx of glutamine from blood (5 nmol/g/
mm; this study). However, the lumina! N-system
transporter may have an important role in hepatic en-
cephalopathy, for the rate of glutamine accumulation
after portacaval shunting in the rat, a model of hepatic
encephalopathy, is —‘ 5—6 nmol/g/min for the first 24
h (Mans et a!., 1990). This suggests that alterations in
blood-to-brain glutamine transport could significantly
alter brain glutamine accumulation in this condition.
In addition, during hepatic encephalopathy, there is
an increased uptake of L-system substrates that are
precursors for neurotransmitters and this has been hy-
pothesized to lead to a derangement of brain (Zanchin
et al., 1979; Mans et a!., 1983), Changes in brain
and brain endothelial cell glutamine concentration, via
trans-stimulation, have been implicated as a cause of
this change in L-system-mediated transport (James and
Fischer, 1981; Jeppsson et al., 1983; Jeppsson et a!.,
1985). The Na-dependent N-system transporter may
be a major determinant of brain endothelial cell gluta-
mine concentration and, thus, the degree of trans-stim-
ulation.
In summary, a major component of glutamine trans-
port at the luminal membrane of the BBB is through
the N-system amino acid transporter. This transporter
shows the characteristics of Na dependence, Li toler-
ance, pH sensitivity, and inhibition by histidine, the
other major N-system substrate.
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